See our latest developments in drug discovery for Cushing’s disease, congenital adrenal hyperplasia (CAH), congenital hyperinsulinism (HI), and hypercalcemia.
Be Your Own Advocate
Acromegaly patients share the importance of being your own advocate.
See our latest developments in drug discovery for Cushing’s disease, congenital adrenal hyperplasia (CAH), congenital hyperinsulinism (HI), and hypercalcemia.
Be Your Own Advocate
Acromegaly patients share the importance of being your own advocate.
A fuller,freer life iswithin reach.
Living with a rare endocrine disease can be challenging. We’re working on new treatments to these life-threatening conditions that you need and deserve. Like an oral treatment for acromegaly called paltusotine, which will be a welcome development for many patients and their families.
A company as rare as the diseaseswe focus on.
Few companies focus exclusively on endocrine diseases. We do. Many patients have longed for better therapies that offer symptom improvement and a better quality of life. We’re innovating to try to make this happen. Bringing cutting-edge science to underserved patients is important work. We do it every day.
We've built a better workplace to help patients build better lives.
“Focused intensity” is how we like to describe our approach to our jobs. There’s a lot of work to do when you’re trying to improve patients’ lives. Lots of discoveries to make. Lots of goals to meet. But we love the challenges and embrace them head-on. Intrigued?